logo_centered_440x386.png
PacBio Grants Equity Incentive Award to New Employee
February 14, 2025 23:09 ET | PacBio
MENLO PARK, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
logo_centered_440x386.png
PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results
February 13, 2025 16:05 ET | PacBio
MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth quarter results ...
logo_centered_440x386.png
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
February 03, 2025 09:05 ET | PacBio
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David...
logo_centered_440x386.png
PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025
January 30, 2025 16:05 ET | PacBio
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on...
logo_centered_440x386.png
PacBio Announces Appointment of Chris Smith to Board of Directors
January 30, 2025 09:05 ET | PacBio
MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of Chris Smith...
logo_centered_440x386.png
PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics
January 29, 2025 09:05 ET | PacBio
MENLO PARK, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leader in high-quality, long-read sequencing, is proud to announce its critical role in a study to be published in...
logo_centered_440x386.png
PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider
January 23, 2025 09:05 ET | PacBio
MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food...
logo_centered_440x386.png
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
January 14, 2025 09:05 ET | PacBio
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud...
logo_centered_440x386.png
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
January 14, 2025 09:00 ET | PacBio
Commenced shipment of the Vega™ benchtop system ahead of schedule, bringing HiFi sequencing to more customers Launched SPRQ chemistry, enabling the sub-$500 HiFi genome on the Revio® system ...
logo_centered_440x386.png
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
January 10, 2025 06:05 ET | PacBio
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and...